| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Physiology and Growth |
Departments of Biochemistry and Child Health, University of Missouri, Columbia, MO, USA1
Author for correspondence: Deborah L. Chance. Tel: +1 573 884 6078. Fax: +1 573 882 4287. e-mail: ChanceD{at}health.missouri.edu
Pseudomonas aeruginosa is a key player in the pathology and morbidity of cystic fibrosis. Chronic obstructive pulmonary disease, which results from the most common and severe mutations in this genetic disorder, typically includes chronic infection with P. aeruginosa which, even with rugged antibiotic and physical therapy regimens, is rarely eradicated. It is not known whether the increased oligosaccharide sulfation characteristic of cystic fibrosis tracheobronchial mucins plays a role in the survival of P. aeruginosa in the airway. In this study, sulfated monosaccharides were synthesized and tested for their effects on the growth of clinical isolates and laboratory strains of this organism when supplied as the sole carbon source in vitro. Carbohydrate sulfation was observed to reduce, but not prohibit, growth of P. aeruginosa on carbohydrates normally utilized in their nonsulfated form. The various sulfated sugars employed as the sole carbon source gave characteristic and consistent growth profiles and maximum growth values across the strains tested. P. aeruginosa isolates from patients with cystic fibrosis often express a mucoid phenotype, which is thought to contribute to their ability to survive in harsh conditions. Carbohydrate sulfation effects on growth did not differ significantly between mucoid and nonmucoid strains. These results suggest that the additional sulfation of tracheobronchial mucin documented in cystic fibrosis may in fact contribute to the mucin’s resistance to utilization by P. aeruginosa and potentially other pathogens, providing an additional level of host protection, and limiting the available nutrient pool and thereby bacterial growth.
Keywords: Pseudomonas aeruginosa, growth, sulfate, mucin, cystic fibrosis
Abbreviations: CF, cystic fibrosis
a Present address: Department of Molecular Microbiology & Immunology, M616 Medical Sciences Building, University of Missouri, Columbia, MO 65212, USA.
This article has been cited by other articles:
|
|
 |
|
  M. A. Kamboures, D. R. Blake, D. M. Cooper, R. L. Newcomb, M. Barker, J. K. Larson, S. Meinardi, E. Nussbaum, and F. S. Rowland Breath sulfides and pulmonary function in cystic fibrosis PNAS, November 1, 2005; 102(44): 15762 - 15767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Aristoteli and M. D. P. Willcox Mucin Degradation Mechanisms by Distinct Pseudomonas aeruginosa Isolates In Vitro Infect. Immun., October 1, 2003; 71(10): 5565 - 5575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Deplancke, O. Vidal, D. Ganessunker, S. M Donovan, R. I Mackie, and H R. Gaskins Selective growth of mucolytic bacteria including Clostridium perfringens in a neonatal piglet model of total parenteral nutrition Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1117 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Conour, D. Ganessunker, K. A. Tappenden, S. M. Donovan, and H. R. Gaskins Acidomucin goblet cell expansion induced by parenteral nutrition in the small intestine of piglets Am J Physiol Gastrointest Liver Physiol, November 1, 2002; 283(5): G1185 - G1196. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
